CoChat

Somatic TP53 variants frequently confound germ-line testing results

Open access
Weitzel, Jeffrey N., Chao, Elizabeth C., Nehoray, Bita, Van Tongeren, Lily R., LaDuca, Holly, Blazer, Kathleen R., Slavin, Thomas, Pesaran, Tina, Rybak, Christina, Solomon, Ilana, Niell-Swiller, Mariana, Dolinsky, Jill S., Castillo, Danielle, Elliott, Aaron, Gau, Chia-Ling, Speare, Virginia, Jasperson, Kory · 2018 · Genetics in Medicine
Cited by 127

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Blood/saliva DNA is thought to represent the germ line in genetic cancer-risk assessment. Cases with pathogenic TP53 variants detected by multigene panel testing are often discordant with Li-Fraumeni syndrome, raising concern about misinterpretation of acquired aberrant clonal expansions (ACEs) with TP53 variants as germ-line results. Pathogenic TP53 variants with abnormal next-generation sequencing metrics (e.g., decreased ratio (<25%) of mutant to wild-type allele, more than two detected alleles) were selected from a CLIA laboratory testing cohort. Alternate tissues and/or close relatives were tested to distinguish between ACE and germ-line status. Clinical data and Li-Fraumeni syndrome testing criteria were examined. Among 114,630 multigene panel tests and 1,454 TP53 gene-specific analyses, abnormal next-generation sequencing metrics were observed in 20% of 353 TP53-positive results, and ACE was confirmed for 91% of cases with ancillary materials, most of these due to clonal hematopoiesis. Only four met Chompret criteria. Individuals with ACE were older (50 years vs. 33.7; P = 0.02) and were identified more frequently in multigene panel tests (66/285; 23.2%) than in TP53 gene-specific tests (6/68; 8.8%, P = 0.005). ACE confounds germ-line diagnosis, may portend hematologic malignancy, and may provoke unwarranted clinical interventions. Ancillary testing to confirm germ-line status should precede Li-Fraumeni syndrome management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/gim.2017.196

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 127

Metadata

Authors
Weitzel, J. N., Chao, E. C., Nehoray, B., Van Tongeren, L. R., LaDuca, H., Blazer, K. R., Slavin, T., Pesaran, T., Rybak, C., Solomon, I., Niell-Swiller, M., Dolinsky, J. S., Castillo, D., Elliott, A., Gau, C.-L., Speare, V., & Jasperson, K.
Venue
Genetics in Medicine
Publisher
Elsevier BV
Published
2018-08
Volume
20
Issue
8
Pages
809-816
ISSN
1098-3600 (ISSN-L)
OpenAlex
W2774371853
Cited by
127
References
6
FWCI
9.98
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Somatic TP53 variants frequently confound germ-line testing results. https://app.cochat.ai/papers/10.1038/gim.2017.196
The paper
Weitzel, J. N., Chao, E. C., Nehoray, B., Van Tongeren, L. R., LaDuca, H., Blazer, K. R., Slavin, T., Pesaran, T., Rybak, C., Solomon, I., Niell-Swiller, M., Dolinsky, J. S., Castillo, D., Elliott, A., Gau, C.-L., Speare, V., & Jasperson, K. (2018). Somatic TP53 variants frequently confound germ-line testing results. Genetics in Medicine. https://doi.org/10.1038/gim.2017.196

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.